Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil Assessed by 24-Hour Ambulatory Blood Pressure Monitoring in Patients with Essential Hypertension

By Brunner H.R.  

Clinical Drug Investigation, Vol. 23, Iss. 7, 2003-01 ,pp. : 419-430

Adis International

Access to resources Recommend Favorite

Use of 24-Hour Ambulatory Blood Pressure Monitoring to Assess Antihypertensive Efficacy: A Comparison of Olmesartan Medoxomil, Losartan Potassium, Valsartan, and Irbesartan

By Smith David H.G.   Dubiel Robert   Jones Michael  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 41-50

Adis International

Access to resources Recommend Favorite

Antihypertensive Efficacy of Olmesartan Medoxomil and Candesartan Cilexetil in Achieving 24-Hour Blood Pressure Reductions and Ambulatory Blood Pressure Goals

By Brunner Hans R.  

Clinical Drug Investigation, Vol. 26, Iss. 4, 2006-01 ,pp. : 185-193

Adis International

Access to resources Recommend Favorite

Seated Cuff Blood Pressure-Lowering Efficacy of an Olmesartan Medoxomil-Based Treatment Regimen in Patients with Type 2 Diabetes Mellitus

By Kereiakes Dean J.  

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 251-257

Adis International

Access to resources Recommend Favorite

Effect of an Olmesartan Medoxomil-Based Treatment Algorithm on Systolic Blood Pressure in Patients with Stage 1 or 2 Hypertension: A Randomized, Double-Blind, Placebo-Controlled Study

By Kereiakes Dean J.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 4, 2010-08 ,pp. : 239-246

Adis International

Access to resources Recommend Favorite